Brooke Clarke
Public Communications Contact bei SYNAIRGEN PLC
Profil
Brooke Clarke is currently the Senior Vice President & Head-Communications at Synairgen Plc since 2021.
Prior to this, she worked as the Global Head-Communications & Corporate Affairs at Hikma Pharmaceuticals Plc from 2016 to 2021 and as the Senior Director-Global Corporate Communications at Shire Plc from 2011 to 2016.
Ms. Clarke has a graduate degree from the University of London and an undergraduate degree from the University of Michigan.
Aktive Positionen von Brooke Clarke
| Unternehmen | Position | Beginn |
|---|---|---|
| SYNAIRGEN PLC | Public Communications Contact | 01.09.2021 |
Ehemalige bekannte Positionen von Brooke Clarke
| Unternehmen | Position | Ende |
|---|---|---|
| HIKMA PHARMACEUTICALS PLC | Public Communications Contact | 01.02.2021 |
| SHIRE | Public Communications Contact | 01.09.2016 |
Ausbildung von Brooke Clarke
| University of Michigan | Undergraduate Degree |
| University of London | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SYNAIRGEN PLC | Health Technology |
| HIKMA PHARMACEUTICALS PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
